Related references
Note: Only part of the references are listed.A review of the antibacterial activity of Hypericum perforatum L.
Zeb Saddiqe et al.
JOURNAL OF ETHNOPHARMACOLOGY (2010)
Diversity of soil mycobacterium isolates from three sites that degrade polycyclic aromatic hydrocarbons
C. D. Miller et al.
JOURNAL OF APPLIED MICROBIOLOGY (2007)
Hyperforin inhibits P-gp and BCRP activities in chronic lymphocytic leukaemia cells and myeloid cells
Claire Quiney et al.
LEUKEMIA & LYMPHOMA (2007)
Hyperforin:: More than an antidepressant bioactive compound?
Miguel A. Medina et al.
LIFE SCIENCES (2006)
New drug candidates and therapeutic targets for tuberculosis therapy
Y Zhang et al.
DRUG DISCOVERY TODAY (2006)
Variation in concentrations of major or bioactive compounds of St. John's wort: Effects of harvesting time, temperature and germplasm
MA Couceiro et al.
PLANT SCIENCE (2006)
Extracts from St John's Wort and their antimicrobial activity
P Avato et al.
PHYTOTHERAPY RESEARCH (2004)
Determination of major constituents in St. John's Wort under different extraction conditions
P Avato et al.
PHARMACEUTICAL BIOLOGY (2004)
Isolation and characterization of polycyclic aromatic hydrocarbon-degrading mycobacterium isolates from soil
CD Miller et al.
MICROBIAL ECOLOGY (2004)
Isoniazid resistance of exponentially growing Mycobacterium smegmatis biofilm culture
R Teng et al.
FEMS MICROBIOLOGY LETTERS (2003)
Anti-inflammatory actions of St. John's wort:: Inhibition of human inducible nitric-oxide synthase expression by down-regulating signal transducer and activator of transcription-1α (STAT-1α) activation
E Tedeschi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Hyperforin a constituent of St John's wort (Hypericum perforatum L.) extract induces apoptosis by triggering activation of caspases and with hypericin synergistically exerts cytotoxicity towards human malignant cell lines
K Hostanska et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2003)
Current St. John's wort research from mode of action to clinical efficacy
WE Müller
PHARMACOLOGICAL RESEARCH (2003)
Hypericin in cancer treatment: more light on the way
P Agostinis et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2002)
Inhibition of tumour cell growth by hyperforin, a novel anticancer drug from St. John's wort that acts by induction of apoptosis
CM Schempp et al.
ONCOGENE (2002)
Differential effects of light and nitrogen on production of hypericins and leaf glands in Hypericum perforatum
DP Briskin et al.
PLANT PHYSIOLOGY AND BIOCHEMISTRY (2001)
Global trends in resistance to antituberculosis drugs
MA Espinal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Seasonal variation in hypericin content of Hypericum perforatum L. (St. John's Wort)
IA Southwell et al.
PHYTOCHEMISTRY (2001)
Pharmacokinetics, safety, and antiviral effects of hypericin, a derivative of St. John's Wort plant, in patients with chronic hepatitis C virus infection
JM Jacobson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
St. John's wort (Hypericum perforatum):: a review of the current pharmacological, toxicological, and clinical literature
JM Greeson et al.
PSYCHOPHARMACOLOGY (2001)
St John's wort for depression -: A systematic review
B Gaster et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
Share Paper
